Alnylam Pharmaceuticals (ALNY) Other Gross PP&E Adjustments: 2009-2025
Historic Other Gross PP&E Adjustments for Alnylam Pharmaceuticals (ALNY) over the last 7 years, with Sep 2025 value amounting to -$191.4 million.
- Alnylam Pharmaceuticals' Other Gross PP&E Adjustments rose 2.55% to -$191.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.0 million, marking a year-over-year increase of 69.32%. This contributed to the annual value of $562.0 million for FY2024, which is 6.39% up from last year.
- Alnylam Pharmaceuticals' Other Gross PP&E Adjustments amounted to -$191.4 million in Q3 2025, which was up 0.53% from -$192.4 million recorded in Q2 2025.
- Alnylam Pharmaceuticals' Other Gross PP&E Adjustments' 5-year high stood at $562.0 million during Q4 2024, with a 5-year trough of -$238.1 million in Q2 2021.
- For the 3-year period, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$64.4 million, with its median value being -$196.4 million (2024).
- Over the last 5 years, Alnylam Pharmaceuticals' Other Gross PP&E Adjustments had its largest YoY gain of 24.19% in 2021, and its largest YoY loss of 7.20% in 2021.
- Quarterly analysis of 5 years shows Alnylam Pharmaceuticals' Other Gross PP&E Adjustments stood at $392.9 million in 2021, then grew by 17.57% to $462.0 million in 2022, then increased by 14.35% to $528.2 million in 2023, then grew by 6.39% to $562.0 million in 2024, then grew by 2.55% to -$191.4 million in 2025.
- Its last three reported values are -$191.4 million in Q3 2025, -$192.4 million for Q2 2025, and -$197.2 million during Q1 2025.